Target intelligence / Profile preview

Carboxypeptidase B2 (CPB2)

Target
CPB2
Molecular classification
Enzyme, Metallocarboxypeptidase, Peptidase M14 family
01

Overview

Carboxypeptidase B2 (CPB2), also known as Carboxypeptidase U (CPU), Plasma carboxypeptidase B (pCPB), or Thrombin-activatable fibrinolysis inhibitor (TAFI), is a human enzyme that plays important roles in regulating fibrinolysis and modulating the activity of biologically active peptides. It is a metallocarboxypeptidase that cleaves C-terminal basic amino acids, specifically arginine or lysine, from peptides and proteins. CPB2 is synthesized as an inactive zymogen and activated by proteolytic cleavage. After activation, it downregulates fibrinolysis by reducing plasminogen binding to fibrin and regulates peptide hormones by cleaving C-terminal arginine or lysine residues. Genetic polymorphisms in CPB2 may influence individual susceptibility to thrombosis or bleeding disorders.

Other names
CPUpCPBTAFICarboxypeptidase UPlasma carboxypeptidase BThrombin-activatable fibrinolysis inhibitor
02

Mechanism of action

Inhibition of carboxypeptidase activity, modulation of fibrinolysis, regulation of peptide hormone activity

03

Biological functions

Regulation of fibrinolysisModulation of peptide hormone activityRegulation of complement cascadeInhibition of fibrinolysisModulation of inflammatory responses
04

Disease associations

ThrombosisBleeding disorders
05

Safety considerations

Altered regulation of clot stability and breakdown potentially leading to thrombosis or bleeding disorders

Beyond the preview

Go deeper on Carboxypeptidase B2 (CPB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carboxypeptidase B2 (CPB2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call